Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.007 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.007 |